Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Basis of preparation (Tables)

v3.23.1
Basis of preparation (Tables)
 12 Months Ended
Dec. 31, 2022
Basis of preparation.  
Schedule of company's subsidiary

​

​

​

​

​

​

​

Name

    

Place of Incorporation

    

Ownership Percentage

 

XORTX Pharma Corp.

 

Canada

 

100

%

​